Functional Skills

Procurement
Business Development
Medical Affairs
Leadership Development
Commercial Due Diligence
Venture Capital Investing

Software Skills

PowerBI
Microsoft Office

Sector Experience

Business Services
Consumer Goods
Healthcare
Life Sciences & Pharma
Technology

Experience

Fortis Industries, LLC Corporate Strategy & Development
President & Chief Executive Officer
1/2018 - 5/2024
Founding member of Fortis Industries, specializing in blending data analytics, due diligence, and a strong industry network to proactively identify, engage, and evaluate potential investments which fit with client's investment strategy and have the potential to meet company portfolio goals.
• Assessed Tunisia's health tech/life science entrepreneurial ecosystem and investment landscape through a field visit, evaluating scientific research, startups, investors, incubators, and support programs. Provided actionable recommendations leading to the establishment of a technology transfer office in Tunisia.
• Conduct in-depth research and analysis of the healthcare market landscape, providing comprehensive market assessments, competitive analyses, and identification of growth opportunities and potential risks.
• Prepare and present opportunity assessments to corporate senior leadership teams or investment funds, highlighting key aspects of investment opportunities, including differentiatio

The National Institutes of Health, SEED Corporate Strategy & Development
Entrepreneur in Residence
1/2021 - 1/2023
Served as a consultant Entrepreneur in Residence, providing business development support services to National Institutes of Health SBIR/STTR awardee companies.
• Mentored awardees in crafting and refining pitch presentations, enhancing their fundraising capabilities.
• Analyzed and advised on competitive landscape positioning for SBIR/STTR awardees, significantly improving their market differentiation and commercialization strategies.
• Developed and implemented payer development and market access strategies for healthcare-focused awardees, ensuring product alignment with reimbursement requirements and enhancing market uptake.
• Collaborated with NIH SBIR/STTR awardees to pinpoint and engage potential investors.
• Provided expert guidance on navigating complex funding landscapes, including grant writing support and direct introductions to non-dilutive funding sources.

Sanusek. LLC Corporate Strategy & Development
President & Chief Executive Officer
1/2014 - 1/2017
Collaborated with public and private entities across Africa, launching and scaling healthcare-focused projects, including point-of-care laboratory development, biomedical equipment procurement and training, and health facility planning.
• Established partnerships with biomedical equipment training programs, launching educational and onsite training initiatives in Kenya and Tanzania.
• Identified and vetted medical equipment manufacturers and suppliers, facilitating equipment and STEM educational product exports to multiple African countries.

BLH TECHNOLOGIES, INC. Corporate Strategy & Development
Chief Medical Officer
1/2012 - 1/2014
Identified and evaluated over 50 public health project opportunities and led new marketing initiatives to expand the Global Health program into Africa. Advised the CEO on the go no go market growth opportunities related to global public health.
• Contributed substantially to new business development efforts by participating in the production of proposals which resulted in winning federal government bids worth $1.5M+.
• Worked collaboratively with the senior management to coordinate organizational decision-making around bidding priorities and proposal development for domestic and global health projects.

Syan Biosciences, LLC Corporate Strategy & Development
Co-Founder/Chief Medical Officer
1/2007 - 1/2012
Co-Founded Syan Biosciences and contributed to the development of the business and product strategy to develop a novel point-of-care (POC) diagnostic test for the developing world.
• Identified and qualified point-of-care diagnostic in-licensing and seed funding opportunities including non dilutive funding and served as company spokesperson in external partnering, investor, and scientific meetings. Managed relationships with key partners including universities and grant funding agencies.
• Drove due diligence activities in the areas of IP, probability of technical, regulatory, and commercialization success.
● ADDITIONAL WORK HISTORY